CGM in Early Gestational Diabetes Improved Outcomes - Report - MDSpire

CGM in Early Gestational Diabetes Improved Outcomes

Secondary outcomes favored CGM, including fewer preterm births and neonatal intensive care unit admissions.

  • By

  • Kathryn Wighton

  • April 22, 2026

  • 3 min

Share

Clinical Report: CGM in Early Gestational Diabetes Improved Outcomes

Overview

Revise to specify that CGM did not improve time in range but was associated with better maternal and neonatal outcomes.

Background

Gestational diabetes poses significant risks for both maternal and neonatal health, making effective glycemic control essential. Continuous glucose monitoring has emerged as a potential tool to enhance diabetes management during pregnancy. Understanding the impact of CGM on outcomes can inform clinical practices and guidelines for managing gestational diabetes.

Data Highlights

OutcomeCGM GroupControl Group
Time in Range (63-140 mg/dL)89%87%
Preterm Birth Rate7%18%
Failed Induction Leading to Cesarean Delivery20%44%
Large-for-Gestational-Age Birth5%18%
NICU Admission Rate23%45%

Key Findings

  • CGM did not improve time in range compared to self-monitoring (89% vs 87%).
  • CGM group had a lower preterm birth rate (7% vs 18%).
  • Failed induction leading to cesarean delivery was lower in the CGM group (20% vs 44%).
  • Neonatal intensive care unit admissions were reduced in the CGM group (23% vs 45%).
  • Patients reported high satisfaction with CGM, with a mean benefit score of 4.3 out of 5.

Clinical Implications

Highlight the necessity for further research to validate CGM's effectiveness in gestational diabetes.

Conclusion

CGM shows promise in improving maternal and neonatal health outcomes in gestational diabetes, despite no significant change in time in range. Further research is warranted to explore its full potential in this population.

References

  1. Elkind-Hirsch K, et al., Diabetes, Obesity and Metabolism, 2023 -- CGM in Early Gestational Diabetes Improved Outcomes
  2. Utilizing Diabetes Technology for Managing Pregnant Patients with Diabetes, The Journal of Clinical Endocrinology & Metabolism, 2023
  3. Artificial Intelligence Model for Predicting Large-for-Gestational-Age Infants in Pregnant Women with Gestational Diabetes Mellitus, The Journal of Clinical Endocrinology & Metabolism, 2023
  4. Comparative Analysis of Early Intervention and Monitoring in Gestational Diabetes Mellitus: A Systematic Review and Meta-Analysis of Randomized Controlled Trials, The Journal of Clinical Endocrinology & Metabolism, 2023
  5. Variability in Gestational Diabetes and Its Association with Negative Pregnancy Outcomes: Findings from a Cohort Analysis, The Journal of Clinical Endocrinology & Metabolism, 2023
  6. Guidance on Glucose Monitoring During Pregnancy
  7. Continuous glucose monitoring in pregnant women with type 1 diabetes (CONCEPTT)
  8. Continuous glucose monitoring in early gestational diabetes improves maternal and neonatal outcomes—The Steady Sugar trial - PMC

Original Source(s)

CGM in Early Gestational Diabetes Improved Outcomes

  • by Kathryn Wighton

  • April 22, 2026

Related Content

Makary Resigns as FDA Commissioner Following Policy Disputes

Transition follows disputes over vaccine policy, food additive regulation, and flavored vaping product authorization

Women Overdue for Cancer Screenings

More than 80% of women who were partially up to date reported a wellness visit in the prior year, suggesting missed opportunities for screening engagement in primary care.

Vaginal DNA Assay Shows Promise

A two-marker methylated DNA assay identified endometrial cancer with 96% sensitivity in self-collected vaginal fluid — but prospective validation is needed before it can reduce biopsies in routine care.